Therapies for Active Rheumatoid Arthritis after Methotrexate Failure
EBM, Landmark Research
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis (RAVE)
EBM, Landmark Research
Methotrexate and Mortality in Patients with Rheumatoid Arthritis
EBM, Landmark Research
Methotrexate is the most common choice for disease-modifying anti-rheumatic drug (DMARD) for rheumatoid arthritis. This prospective study assesses the effect of methotrexate on mortality in a cohort of patients with rheumatoid arthritis. Some questions to consider while reviewing this article:…
Mycophenolate vs Cyclophosphamide in SLE Nephritis
EBM, Landmark Research
Neuropsychiatric Lupus
Morning Report
Excellent morning report today with Thomas Vu on Neuropsychiatric Lupus! Take a look at on the latest review on neuropsychiatric SLE: Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives on PubMed